Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.
发现 BMS-986365，一种首创的双重雄激素受体配体导向降解剂和拮抗剂，用于治疗晚期前列腺癌。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0471
Nayak Surendra, Norris John D, Ammirante Massimo, Rychak Emily, Wardell Suzanne E, Liao Debbie, Toyama Brandon, Kandimalla Raju, Christoforou Andy, Tsuji Toshiya, Liu Ken, Tran Minerva, Meiring Joseph, Reiss Samantha, Piccotti Joseph R, Baughman Joshua M, Fontanillo Celia, Khater Marwa, Mortensen Deborah S, Cathers Brian, Bence Neil, Pierce Daniel W, Plantevin-Krenitsky Veronique, Rathkopf Dana, Hansen Joshua D, Hamann Lawrence G, Narla Rama Krishna, Arora Vivek K, McDonnell Donald P, Rolfe Mark, Xu Shuichan
